Lacnotuzumab (MCS110) 是一种靶向CSF-1的中和人源化 IgG1/κ 单克隆抗体，可防止 CSF-1 激活 CSF-1R。Lacnotuzumab 可用于色素沉着绒毛结节性滑膜炎的研究。
| 生物活性 | Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targetingCSF-1that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis[1][2]. |
| IC50& Target | |
体内研究
(In Vivo) | Lacnotuzumab 中和食蟹猴重组和血清衍生形式的 CSF-1，但它不识别啮齿动物或兔的 CSF-1[2]。
|
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com